Professor Simon D Taylor-Robinson

Publications


Journals

  • Montagnese S; Schiff S; De Rui M; Crossey MM; Amodio P; Taylor-Robinson SD. (May 2012). Neuropsychological tools in hepatology: a survival guide for the clinician. J Viral Hepat. 19:307-315. DOI.
  • Cobbold JF; Patel D; Fitzpatrick JA; Patel N; Crossey MM; Abdalla MS; Goldin RD; Vennart W; et alThomas HC; Taylor-Robinson SD. (May 2012). Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C. Hepatol Res. 42:515-522. DOI.
  • Bajaj JS; Gillevet PM; Patel NR; Ahluwalia V; Ridlon JM; Kettenmann B; Schubert CM; Sikaroodi M; et alHeuman DM; Crossey MM; Bell DE; Hylemon PB; Fatouros PP; Taylor-Robinson SD. (Jun 2012). A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab Brain Dis. 27:205-215. DOI.
  • Patel D; McPhail MJ; Cobbold JF; Taylor-Robinson SD. (Feb 2012). Hepatic encephalopathy. Br J Hosp Med (Lond). 73:79-85.
  • Williams HR; Willsmore JD; Cox IJ; Walker DG; Cobbold JF; Taylor-Robinson SD; Orchard TR. (10 Apr 2012). Serum Metabolic Profiling in Inflammatory Bowel Disease. Dig Dis Sci. DOI.
  • Winston A; Puls R; Kerr SJ; Duncombe C; Li PC; Gill JM; Taylor-Robinson SD; Emery S; et alCooper DA; Altair Study Group. (Apr 2012). Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study. HIV Med. 13:245-251. DOI.
  • Patel NR; McPhail MJ; Shariff MI; Keun HC; Taylor-Robinson SD. (Apr 2012). Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology. Expert Rev Gastroenterol Hepatol. 6:239-251. DOI.
  • Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; et alEmery S; Cooper DA; Altair Study Group. (15 Mar 2010). Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clinical Infectious Diseases. 50:920-929. DOI.
  • Patel NR; McPhail MJ; Shariff MI; Keun HC; Taylor-Robinson SD. (Apr 2012). Biofluid metabonomics using (1)H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology. Expert Rev Gastroenterol Hepatol. 6:239-251. DOI.
  • Mehta SR; Godsland IF; Thomas EL; Pavitt DV; Morin SX; Bell JD; Taylor-Robinson SD; Johnston DG. (22 Mar 2012). Intrahepatic Insulin Exposure, Intrahepatocellular Lipid and Regional Body Fat in Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab. DOI.
  • Cobbold JF; Patel D; Taylor-Robinson SD. (20 Mar 2012). Assessment of Inflammation and Fibrosis in Non-Alcoholic Fatty Liver Disease by Imaging-Based Techniques. J Gastroenterol Hepatol. DOI.
  • Winston A; Puls R; Kerr S; Duncombe C; Li P; Gill J; Taylor-Robinson S; Emery S; et alCooper D; ALTAIR Study Group. (Apr 2012). Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study. HIV Medicine. 13:245-251. DOI.
  • Sheridan DA; Bridge SH; Felmlee DJ; Crossey MM; Thomas HC; Taylor-Robinson SD; Toms GL; Neely RD; et alBassendine MF. (10 Mar 2012). Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity. J Hepatol. DOI.
  • McPhail MJ; Patel NR; Taylor-Robinson SD. (Feb 2012). Brain imaging and hepatic encephalopathy. Clin Liver Dis. 16:57-72. DOI.
  • Solanky BS; Sanchez-Canon GJ; Cobbold JF; Taylor-Robinson SD; Bell JD; Scudamore CL; Ross E; Holder JC; et alSo PW; Cox IJ. (Apr 2012). Metabolic profiling of the rat liver after chronic ingestion of alpha-naphthylisothiocyanate using in vivo and ex vivo magnetic resonance spectroscopy. Toxicol Sci. 126:306-316. DOI.
  • Grover VP; Pavese N; Koh SB; Wylezinska M; Saxby BK; Gerhard A; Forton DM; Brooks DJ; et alThomas HC; Taylor-Robinson SD. (Feb 2012). Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat. 19:e89-e96. DOI.
  • Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB. (Apr 2012). Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?. J Hepatol. 56:848-854. DOI.
  • Garvey L; Nelson M; Latch N; Erlwein OW; Allsop JM; Mitchell A; Kaye S; Watson V; et alBack D; Taylor-Robinson SD; Winston A. (Jan 2012). CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study. J Antimicrob Chemother. 67:206-212. DOI.
  • Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; et alTaylor-Robinson SD; Edwards RJ; Khan SA. (1 Sep 2011). Elevated Levels of Neutrophil Gelatinase-Associated Lipocalin in Bile From Patients With Malignant Pancreatobiliary Disease. AMERICAN JOURNAL OF GASTROENTEROLOGY. 106:1711-1717. Author weblink DOI.
  • Lim AK; Patel N; Eckersley RJ; Fitzpatrick J; Crossey MM; Hamilton G; Goldin RD; Thomas HC; et alVennart W; Cosgrove DO; Taylor-Robinson SD. (Oct 2011). A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease. J Viral Hepat. 18:e530-e534. DOI.
  • McPhail MJ; Dhanjal NS; Grover VP; Taylor-Robinson SD. (Feb 2012). Ammonia and cerebral water. Importance of structural analysis of the brain in hepatic encephalopathy. J Hepatol. 56:506. DOI.
  • Wadsworth CA; Dixon PH; Wong JH; Chapman MH; McKay SC; Sharif A; Spalding DR; Pereira SP; et alThomas HC; Taylor-Robinson SD; Whittaker J; Williamson C; Khan SA. (2011). Genetic factors in the pathogenesis of cholangiocarcinoma. Dig Dis. 29:93-97. DOI.
  • Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; et alTaylor-Robinson SD; Edwards RJ; Khan SA. (Sep 2011). Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease. Am J Gastroenterol. 106:1711-1717. DOI.
  • Thomas EL; Parkinson JR; Frost GS; Goldstone AP; Doré CJ; McCarthy JP; Collins AL; Fitzpatrick JA; et alDurighel G; Taylor-Robinson SD; Bell JD. (Jan 2012). The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring). 20:76-87. DOI.
  • Hashim Abdalla MS; Taylor-Robinson SD; Sharif AW; Williams HR; Crossey MM; Badra GA; Thillainayagam AV; Bansi DS; et alThomas HC; Waked IA; Khan SA. (Jun 2011). Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma. HPB (Oxford). 13:385-390. DOI.
  • Hussain SS; Cheent KS; Crossey MM; Khan SA; Jackson JE; Taylor-Robinson SD; Thomas HC. Taha HE (ed). (Oct 2010). Recurrent haemorrhage from facial arteriovenous malformations in decompensated cirrhosis of the liver: Lessons to be learnt. Nile Medical Journal. 2010;1:59-61. Nile Liver Journal. 1, 1:59-61. Publisher weblink Author weblink.
  • Hussein SS; Cheent KS; Khan SA; Jackson JE; Crossey MM; Thomas HC; Taylor-Robinson SD. Al-Mahtab M (ed); Rahman S (ed). (Oct 2010). Management of recurrent bleeding from facial arteriovenous malformations in end-stage liver disease. International Journal of Hepatology. 1, 1:53-54. Publisher weblink Author weblink.
  • Patel KD; Abeysekera KW; Marlais M; McPhail MJ; Thomas HC; Fitzpatrick JA; Lim AK; Taylor-Robinson SD; et alThomas EL. (Feb 2011). Recent advances in imaging hepatic fibrosis and steatosis. Expert Rev Gastroenterol Hepatol. 5:91-104. DOI.
  • Shariff MI; Gomaa AI; Cox IJ; Patel M; Williams HR; Crossey MM; Thillainayagam AV; Thomas HC; et alWaked I; Khan SA; Taylor-Robinson SD. (1 Apr 2011). Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study. J Proteome Res. 10:1828-1836. DOI.
  • Forbes S; Taylor-Robinson SD; Patel N; Allan P; Walker BR; Johnston DG. (Mar 2011). Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes. Diabetologia. 54:641-647. DOI.
  • Garvey L; Higgs C; Mohammed P; Hill A; Allsop JM; Taylor-Robinson SD; Nelson M; Winston A. (Jul 2011). Changes in cerebral function parameters in HIV type 1-infected subjects switching to darunavir/ritonavir either as monotherapy or with nucleoside analogues. AIDS Res Hum Retroviruses. 27:701-703. DOI.
  • Patel M; Shariff MI; Ladep NG; Thillainayagam AV; Thomas HC; Khan SA; Taylor-Robinson SD. (Apr 2012). Hepatocellular carcinoma: diagnostics and screening. J Eval Clin Pract. 18:335-342. DOI.
  • Syms RRA; Young IR; Ahmad MM; Rea M; Wadsworth CA; Taylor-Robinson SD. (1 Sep 2010). Thin-Film Detector System for Internal Magnetic Resonance Imaging. SENSORS AND ACTUATORS A-PHYSICAL. 163:15-24. DOI.
  • Thiyagarajan A; Garvey LJ; Pflugrad H; Maruff P; Scullard G; Main J; Taylor-Robinson SD; Winston A. Cerebral function tests reveal differences in HIV-infected subjects with and without chronic HCV co-infection. Clin Microbiol Infect. Publisher weblink DOI.
  • Ahmad MM; Syms RA; Young IR; Mathew B; Casperz W; Taylor-Robinson SD; Wadsworth CA; Gedroyc WM. (30 Jun 2009). Catheter-based flexible microcoil RF detectors for internal magnetic resonance imaging. J Micromech. Microeng. 19:1-10. DOI.
  • Syms RR; Young IR; Ahmad MM; Rea M; Wadsworth CA; Taylor-Robinson SD. (17 May 2010). Thin-film detector system for internal magnetic resonance imaging. Sensors and Actuators A:Physical. 163:15-24. DOI.
  • Mehta SR; Godsland IF; Bell JD; Thomas EL; McCarthy J; Durighel G; Fitzpatrick J; Taylor-Robinson SD; et alJohnston DG. (1 May 2008). INTRA-HEPATIC INSULIN EXPOSURE IS INCREASED IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). ATHEROSCLEROSIS SUPPLEMENTS. 9:121-121. DOI.
  • Bridge SH; Sheridan DA; Felmlee DJ; Nielsen SU; Thomas HC; Taylor-Robinson SD; Neely RD; Toms GL; et alBassendine MF. (May 2011). Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection. Gut. 60:680-687. DOI.
  • Wylezinska M; Cobbold JF; Fitzpatrick J; McPhail MJ; Crossey MM; Thomas HC; Hajnal JV; Vennart W; et alCox IJ; Taylor-Robinson SD. (Apr 2011). A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states. NMR Biomed. 24:231-237. DOI.
  • Milona A; Owen BM; Cobbold JF; Willemsen EC; Cox IJ; Boudjelal M; Cairns W; Schoonjans K; et alTaylor-Robinson SD; Klomp LW; Parker MG; White R; van Mil SW; Williamson C. (Oct 2010). Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function. Hepatology. 52:1341-1349. DOI.
  • Williams HR; Cox IJ; Walker DG; Cobbold JF; Taylor-Robinson SD; Marshall SE; Orchard TR. (2010). Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease. BMC Gastroenterol. 10:108. DOI.
  • Sharif AW; Williams HR; Lampejo T; Khan SA; Bansi DS; Westaby D; Thillainayagam AV; Thomas HC; et alCox IJ; Taylor-Robinson SD. (Aug 2010). Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy. HPB (Oxford). 12:396-402. DOI.
  • Cobbold JF; Anstee QM; Taylor-Robinson SD. (Nov 2010). The importance of fatty liver disease in clinical practice. Proc Nutr Soc. 69:518-527. DOI.
  • McPhail MJ; Bajaj JS; Thomas HC; Taylor-Robinson SD. (Jun 2010). Pathogenesis and diagnosis of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 4:365-378. DOI.
  • McPhail MJ; Senvar N; Thomas HC; Taylor-Robinson SD. (Nov 2010). Modern progress in hepatic encephalopathy. QJM. 103:899-900. DOI.
  • Williams HR; Walker DG; North BV; Taylor-Robinson SD; Orchard TR. (7 May 2010). Metabonomics in ulcerative colitis. J Proteome Res. 9:2794-2795. DOI.
  • Mehta SR; Thomas EL; Patel N; Crofton ME; McCarthy J; Eliahoo J; Morin SX; Fitzpatrick J; et alDurighel G; Goldstone AP; Johnston DG; Bell JD; Taylor-Robinson SD. (Apr 2010). Proton magnetic resonance spectroscopy and ultrasound for hepatic fat quantification. Hepatol Res. 40:399-406. DOI.
  • McPhail MJ; Taylor-Robinson SD. (Mar 2010). The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy. Metab Brain Dis. 25:65-72. DOI.
  • Garvey LJ; Pflugrad H; Thiyagarajan A; Grover VP; Taylor-Robinson SD; Winston A; Clifford DB; Evans SR. (2 Mar 2010). Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology. 74:779. DOI.
  • Patel JH; Cobbold JF; Thomas HC; Taylor-Robinson SD. (May 2010). Hepatitis C and hepatic steatosis. QJM. 103:293-303. DOI.
  • Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; et alEmery S; Cooper DA; Altair Study Group. (15 Mar 2010). Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study. Clin Infect Dis. 50:920-929. DOI.
  • Taylor-Robinson SD; Cobbold JF; Thomas HC. (Feb 2010). Liver stiffness measurements in acute hepatitis B: implications for clinical practice. Eur J Gastroenterol Hepatol. 22:133-134. DOI.
  • Lim AK; Patel N; Eckersley RJ; Cobbold JF; Crossey MM; Cosgrove DO; Goldin RD; Thomas HC; et alTaylor-Robinson SD. (Nov 2010). Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C. J Viral Hepat. 17:778-783. DOI.
  • Shariff MI; Ladep NG; Cox IJ; Williams HR; Okeke E; Malu A; Thillainayagam AV; Crossey MM; et alKhan SA; Thomas HC; Taylor-Robinson SD. (5 Feb 2010). Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population. J Proteome Res. 9:1096-1103. DOI.
  • Cobbold JF; Patel JH; Goldin RD; North BV; Crossey MM; Fitzpatrick J; Wylezinska M; Thomas HC; et alCox IJ; Taylor-Robinson SD. (Jan 2010). Hepatic lipid profiling in chronic hepatitis C: an in vitro and in vivo proton magnetic resonance spectroscopy study. J Hepatol. 52:16-24. DOI.
  • Cobbold JF; Crossey MM; Colman P; Goldin RD; Murphy PS; Patel N; Fitzpatrick J; Vennart W; et alThomas HC; Cox IJ; Taylor-Robinson SD. (Aug 2010). Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C. J Viral Hepat. 17:537-545. DOI.
  • Winston A; Garvey L; Scotney E; Yerrakalva D; Allsop JM; Thomson EC; Grover VP; Main J; et alCox JI; Wylezinska M; Taylor-Robinson SD. (Jun 2010). Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?. J Viral Hepat. 17:419-426. DOI.
  • Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD. (Aug 2009). Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol. 3:353-367. DOI.
  • Williams HRT; Cox IJ; Walker DG; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; et alThomas HJW; Teare JP; Jakobovits S; Zeki S; Welsh KI; Taylor-Robinson SD; Orchard TR. (1 Jul 2009). Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling (vol 104, pg 1435, 2009). AMERICAN JOURNAL OF GASTROENTEROLOGY. 104:1894-1894. Author weblink DOI.
  • Williams HR; Cox IJ; Walker DG; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; et alThomas HJ; Teare JP; Jakobovits S; Zeki S; Welsh KI; Taylor-Robinson SD; Orchard TR. (Jun 2009). Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 104:1435-1444. DOI.
  • Adenugba A; Khan SA; Taylor-Robinson SD; Cox IJ; Toledano MB; Thillainayagam AV; Bansi DS; Thomas HC; et alGibson RW; Beck AJ. (Aug 2009). Polychlorinated biphenyls in bile of patients with biliary tract cancer. Chemosphere. 76:841-846. DOI.
  • Berding G; Banati RB; Buchert R; Chierichetti F; Grover VPB; Kato A; Keiding S; Taylor-Robinson SD. (1 May 2009). Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines. LIVER INTERNATIONAL. 29:621-628. Author weblink DOI.
  • Ariff B; Lloyd CR; Khan S; Shariff M; Thillainayagam AV; Bansi DS; Khan SA; Taylor-Robinson SD; et alLim AK. (21 Mar 2009). Imaging of liver cancer. World J Gastroenterol. 15:1289-1300.
  • Gomaa AI; Khan SA; Leen EL; Waked I; Taylor-Robinson SD. (21 Mar 2009). Diagnosis of hepatocellular carcinoma. World J Gastroenterol. 15:1301-1314.
  • Grier S; Patel N; Kuo YT; Cosgrove DO; Goldin RC; Thomas HC; Taylor-Robinson SD; Lim AK. (Mar 2010). Perihepatic lymph nodes as markers of disease response in patients with hepatitis C-related liver disease: a prospective clinical evaluation. Eur J Gastroenterol Hepatol. 22:257-263. DOI.
  • Williams HR; Cox IJ; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; Thomas HJ; et alTeare JP; Jakobovits S; Zeki SS; Welsh KI; Taylor-Robinson SD; Orchard T. (1 Apr 2008). Crohn's disease is associated with a specific urinary metabolic profile. GASTROENTEROLOGY. 134:A195-A195. Author weblink.
  • Morin SH; Cobbold JF; Lim AK; Eliahoo J; Thomas EL; Mehta SR; Durighel G; Fitzpatrick J; et alBell JD; Taylor-Robinson SD. (Dec 2009). Incidental findings in healthy control research subjects using whole-body MRI. Eur J Radiol. 72:529-533. DOI.
  • Cobbold JFL; Taylor-Robinson SD; Cox IJ. (1 Sep 2008). In vitro proton magnetic resonance spectroscopy of liver tissue informs in vivo hepatic proton magnetic resonance spectroscopy studies. HEPATOLOGY. 48:1016-1016. Author weblink DOI.
  • Khan SA; Toledano MB; Taylor-Robinson SD. (2008). Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 10:77-82. DOI.
  • Williams HRT; Cox IJ; Taylor-Robinson SD. (1 Sep 2008). Metabonomics in hepatic encephalopathy: lucidity emerging from confusion. LIVER INTERNATIONAL. 28:1050-1051. Author weblink DOI.
  • Gomaa AI; Khan SA; Toledano MB; Waked I; Taylor-Robinson SD. (21 Jul 2008). Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. WORLD JOURNAL OF GASTROENTEROLOGY. 14:4300-4308. Author weblink DOI.
  • Cobbold JF; Anstee QM; Goldin RD; Williams HR; Matthews HC; North BV; Absalom N; Thomas HC; et alThursz MR; Cox RD; Taylor-Robinson SD; Cox IJ. (Mar 2009). Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clin Sci (Lond). 116:403-413. DOI.
  • Mehta SR; Thomas EL; Bell JD; Johnston DG; Taylor-Robinson SD. (14 Jun 2008). Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 14:3476-3483.
  • Forton DM; Hamilton G; Allsop JM; Grover VP; Wesnes K; O'Sullivan C; Thomas HC; Taylor-Robinson SD. (Sep 2008). Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol. 49:316-322. DOI.
  • Cobbold JFL; Taylor-Robinson SD. (1 Apr 2008). Liver stiffness values in healthy subjects: Implications for clinical practice. JOURNAL OF HEPATOLOGY. 48:529-531. Author weblink DOI.
  • Cobbold JFL; Taylor-Robinson SD. (1 Feb 2008). Transient elastography in acute hepatitis: All that's stiff is not fibrosis. HEPATOLOGY. 47:370-372. Author weblink DOI.
  • Morin SHX; Lim AKP; Cobbold JFL; Taylor-Robinson SD. (7 Dec 2007). Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions. WORLD JOURNAL OF GASTROENTEROLOGY. 13:5963-5970. Author weblink.
  • Khan SA; Miras A; Pelling M; Taylor-Robinson SD. (1 Dec 2007). Cholangiocarcinoma and its management. GUT. 56:1755-1756. Author weblink DOI.
  • Ladep NG; Taylor-Robinson SD. (1 Oct 2007). Management of liver disease in Nigeria. CLINICAL MEDICINE. 7:439-441. Author weblink.
  • Cobbold JFL; Morin S; Taylor-Robinson SD. (28 Sep 2007). Transient elastography for the assessment of chronic liver disease: Ready for the clinic. WORLD JOURNAL OF GASTROENTEROLOGY. 13:4791-4797. Author weblink.
  • Lim AK; Patel N; Hamilton G; Mylvahan K; Kuo YT; Goldin RD; Taylor-Robinson SD. (Oct 2007). 31P MR spectroscopy in assessment of response to antiviral therapy for hepatitis C virus-related liver disease. AJR Am J Roentgenol. 189:819-823. DOI.
  • Wajed JR; Taylor-Robinson SD; Jackson JE; Stamp GW. (2007). Retroperitoneal haemorrhage in renal angiomyolipoma causing hepatic functional decompensation: a case report. J Med Case Reports. 1:82. DOI.
  • Mehta SR; Godsland IF; Thomas EL; Bell JD; Patel N; Fitzpatrick J; Durighel G; Westerland O; et alAnyakou U; Pavitt D; Taylor-Robinson SD; Johnston DG. (1 Mar 2007). Relationship between intrahepatocellular lipid content and features of the metabolic syndrome in subjects with known nonalcoholic fatty liver disease and healthy volunteers. DIABETIC MEDICINE. 24:45-46. Author weblink.
  • Cobbold JF; Wylezinska M; Cunningham C; Crossey ME; Thomas HC; Cox IJ; Patel N; Taylor-Robinson SD. (Nov 2006). Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques. Gut. 55:1670.
  • Thomas EL; Brynes AE; Hamilton G; Patel N; Spong A; Goldin RD; Frost G; Bell JD; et alTaylor-Robinson SD. (28 Sep 2006). Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol. 12:5813-5819.
  • Cox IJ; Sharif A; Cobbold JFL; Thomas HC; Taylor-Robinson SD. (14 Aug 2006). Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. WORLD J GASTROENTERO. 12:4773-4783.
  • Cox IJ; Sharif A; Cobbold JF; Thomas HC; Taylor-Robinson SD. (14 Aug 2006). Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease. World J Gastroenterol. 12:4773-4783.
  • Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ. (Jul 2006). Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology. 240:130-135. DOI.
  • Grier S; Lim AK; Patel N; Cobbold JF; Thomas HC; Cox IJ; Taylor-Robinson SD. (14 Jun 2006). Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease. World J Gastroenterol. 12:3461-3465.
  • Grover VP; Dresner MA; Forton DM; Counsell S; Larkman DJ; Patel N; Thomas HC; Taylor-Robinson SD. (21 May 2006). Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol. 12:2969-2978.
  • Khan SA; Thomas HC; Davidson BR; Taylor-Robinson SD. (20 May 2006). Cholangiocarcinoma (vol 366, pg 1303, 2005). LANCET. 367:1656-1656. Author weblink.
  • Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine NR; Thomas HC. (May 2006). Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma. Int J Oncol. 28:1269-1277.
  • Forton DM; Taylor-Robinson SD; Thomas HC. (Apr 2006). Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol. 18:333-338.
  • Cagnin A; Taylor-Robinson SD; Forton DM; Banati RB. (Apr 2006). In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut. 55:547-553. DOI.
  • Hamilton G; Allsop JM; Patel N; Forton DM; Thomas HC; O'Sullivan CP; Hajnal JV; Taylor-Robinson SD. (Apr 2006). Variations due to analysis technique in intracellular pH measurements in simulated and in vivo 31P MR spectra of the human brain. J Magn Reson Imaging. 23:459-464. DOI.
  • Rosenfelder NA; Taylor-Robinson SD; Jackson JE; Stamp GW. (Mar 2006). Segmental mediolytic arteriopathy in a patient with intraperitoneal bleeding. Eur J Gastroenterol Hepatol. 18:295-297.
  • Khan SA; Thomas HC; Davidson BR; Taylor-Robinson SD. (8 Oct 2005). Cholangiocarcinoma. Lancet. 366:1303-1314. DOI.
  • Forton DA; Allsop JA; Cox IJ; Hamilton G; Wesnes K; Thomas HC; Taylor-Robinson SD. (1 Oct 2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS. 19:S53-S63. Author weblink DOI.
  • Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD. (Aug 2005). p53 Mutations in human cholangiocarcinoma: a review. Liver Int. 25:704-716. DOI.
  • Dhanjal NS; Sharif AW; Rosenfelder NA; Lim AK; Taylor-Robinson SD. (Jul 2005). Cystic duct dilatation after cholecystectomy in fibropolycystic liver disease. J Hepatol. 43:192. DOI.
  • Khan SA; Cox IJ; Thillainayagam AV; Bansi DS; Thomas HC; Taylor-Robinson SD. (Jul 2005). Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. Eur J Gastroenterol Hepatol. 17:733-738.
  • Müllenbach R; Bennett A; Tetlow N; Patel N; Hamilton G; Cheng F; Chambers J; Howard R; et alTaylor-Robinson SD; Williamson C. (Jun 2005). ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut. 54:829-834. DOI.
  • Lim AK; Patel N; Eckersley RJ; Kuo YT; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; et alBlomley MJ. (Jun 2005). Can Doppler sonography grade the severity of hepatitis C-related liver disease?. AJR Am J Roentgenol. 184:1848-1853.
  • Dhanjal NS; Rosenfelder NA; Graham A; Lim AKP; Taylor-Robinson SD. (1 Jun 2005). Unusual appearances of oesophageal varices on imaging after sclerotherapy. JOURNAL OF HEPATOLOGY. 42:950-950. Author weblink DOI.
  • Taylor-Robinson D; Sharif AW; Dhanjal NS; Taylor-Robinson SD. (May 2005). Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis. J Hepatol. 42:779-780. DOI.
  • Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD. (Apr 2005). In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int. 25:273-281. DOI.
  • Forton DM; Patel N; Oatridge A; Hamilton G; Hajnal JV; Thomas HC; Taylor-Robinson SD; Prince M; et alGoldblatt J; Bassendine M; Jones DE. (Mar 2005). Fatigue in primary biliary cirrhosis. Gut. 54:438.
  • Hasegawa H; Sandhu GS; Thillainayagam AV; Strickland NH; Taylor-Robinson SD. (Feb 2005). A mediastinal mass in end-stage liver disease. J R Soc Med. 98:65-66. DOI.
  • Thomas EL; Hamilton G; Patel N; O'Dwyer R; Doré CJ; Goldin RD; Bell JD; Taylor-Robinson SD. (Jan 2005). Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut. 54:122-127. DOI.
  • Lim AK; Taylor-Robinson SD; Patel N; Eckersley RJ; Goldin RD; Hamilton G; Foster GR; Thomas HC; et alCosgrove DO; Blomley MJ. (Jan 2005). Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut. 54:128-133. DOI.
  • Forton DM; Thomas HC; Taylor-Robinson SD. (Dec 2004). Central nervous system involvement in hepatitis C virus infection. Metab Brain Dis. 19:383-391.
  • Patel N; White S; Dhanjal NS; Oatridge A; Taylor-Robinson SD. (Dec 2004). Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metab Brain Dis. 19:431-445.
  • Dave U; Taylor-Robinson SD; Walker MM; Mahon M; Puri BK; Thursz MR; DeSouza NM; Cox IJ. (Nov 2004). In vitro 1H-magnetic resonance spectroscopy of Barrett's esophageal mucosa using magic angle spinning techniques. Eur J Gastroenterol Hepatol. 16:1199-1205.
  • Lim AK; Patel N; Eckersley RJ; Taylor-Robinson SD; Cosgrove DO; Blomley MJ. (Jun 2004). Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers. Radiology. 231:785-788. DOI.
  • Forton DM; Karayiannis P; Mahmud N; Taylor-Robinson SD; Thomas HC. (May 2004). Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol. 78:5170-5183.
  • Khan SA; Sharif AW; Taylor-Robinson SD. (May 2004). Photodynamic therapy significantly improves survival outcomes in people with non-resectable cholangiocarcinoma. Cancer Treat Rev. 30:315-318. DOI.
  • Forton DM; Patel N; Prince M; Oatridge A; Hamilton G; Goldblatt J; Allsop JM; Hajnal JV; et alThomas HC; Bassendine M; Jones DE; Taylor-Robinson SD. (Apr 2004). Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut. 53:587-592.
  • Hodgson RS; Taylor-Robinson SD; Jackson JE. (Feb 2004). Haematochezia in Crohn's disease caused by late-onset haemobilia following percutaneous liver biopsy. Eur J Gastroenterol Hepatol. 16:229-232.
  • Dave UR; Williams AD; Wilson JA; Amin Z; Gilderdale DJ; Larkman DJ; Thursz MR; Taylor-Robinson SD; et aldeSouza NM. (Jan 2004). Esophageal cancer staging with endoscopic MR imaging: pilot study. Radiology. 230:281-286. DOI.
  • Bhakoo KK; Bell JD; Cox IJ; Taylor-Robinson SD. (2004). The application of magnetic resonance imaging and spectroscopy to gene therapy. Methods Enzymol. 386:303-313. DOI.
  • Chappell KE; Patel N; Gatehouse PD; Main J; Puri BK; Taylor-Robinson SD; Bydder GM. (Dec 2003). Magnetic resonance imaging of the liver with ultrashort TE (UTE) pulse sequences. J Magn Reson Imaging. 18:709-713. DOI.
  • Dhanjal NS; Cox IJ; Taylor-Robinson SD. (Sep 2003). In vivo electron spin resonance spectroscopy: what use is it to gastroenterologists?. Gut. 52:1236-1237.
  • Blomley MJ; Lim AK; Harvey CJ; Patel N; Eckersley RJ; Basilico R; Heckemann R; Urbank A; et alCosgrove DO; Taylor-Robinson SD. (Aug 2003). Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut. 52:1188-1193.
  • Forton DM; Thomas HC; Taylor-Robinson SD. (Aug 2003). Quality of life and cognitive function in chronic hepatitis C - what to measure?. J Hepatol. 39:272-274.
  • Hamilton G; Patel N; Forton DM; Hajnal JV; Taylor-Robinson SD. (May 2003). Prior knowledge for time domain quantification of in vivo brain or liver 31P MR spectra. NMR Biomed. 16:168-176. DOI.
  • Khan SA; Carmichael PL; Taylor-Robinson SD; Habib N; Thomas HC. (Apr 2003). DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma. Gut. 52:586-591.
  • Lim AK; Patel N; Hamilton G; Hajnal JV; Goldin RD; Taylor-Robinson SD. (Apr 2003). The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology. 37:788-794. DOI.
  • Forton DM; Taylor-Robinson SD; Thomas HC. (Mar 2003). Cerebral dysfunction in chronic hepatitis C infection. J Viral Hepat. 10:81-86.
  • Hamilton G; Mathur R; Allsop JM; Forton DM; Dhanjal NS; Shaw RJ; Taylor-Robinson SD. (Mar 2003). Changes in brain intracellular pH and membrane phospholipids on oxygen therapy in hypoxic patients with chronic obstructive pulmonary disease. Metab Brain Dis. 18:95-109.
  • Dick EA; Joarder R; de Jode M; Taylor-Robinson SD; Thomas HC; Foster GR; Gedroyc WM. (Feb 2003). MR-guided laser thermal ablation of primary and secondary liver tumours. Clin Radiol. 58:112-120.
  • Lim AK; Hamilton G; Patel N; Bell JD; Taylor-Robinson SD. (Jan 2003). H MR spectroscopy in the evaluation of the severity of chronic liver disease. Radiology. 226:288-289.
  • Khan SA; Beck A; Carmichael PL; Taylor-Robinson SD. (1 Jan 2003). Unfriendly chemicals in pancreatic cancer - Invited commentary. PANCREATOLOGY. 3:7-8. Author weblink.
  • Khan SA; Beck A; Carmichael PL; Taylor-Robinson SD. (2003). Unfriendly chemicals in pancreatic cancer. Pancreatology. 3:7-8.
  • Khan SA; Taylor-Robinson SD; Toledano MB; Beck A; Elliott P; Thomas HC. (Dec 2002). Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 37:806-813.
  • Harvey CJ; Lim AK; Blomley MJ; Taylor-Robinson SD; Gedroyc WM; Cosgrove DO. (Dec 2002). Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. Eur Radiol. 12 Suppl 3:S70-S73. DOI.
  • Khan SA; Davidson BR; Goldin R; Pereira SP; Rosenberg WMC; Taylor-Robinson SD; Thillainayagam AV; Thomas HC; et alThursz MR; Wasan H. (1 Nov 2002). Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. GUT. 51:1-9. Author weblink.
  • Khan SA; Davidson BR; Goldin R; Pereira SP; Rosenberg WM; Taylor-Robinson SD; Thillainayagam AV; Thomas HC; et alThursz MR; Wasan H; British Society of Gastroenterology. (Nov 2002). Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 51 Suppl 6:VI1-VI9.
  • Forton DM; Wright M; Knapp S; Thursz MR; Taylor-Robinson SD; Thomas HC. (Nov 2002). New insights into hepatitis C. Clin Med. 2:554-559.
  • Oatridge A; Barnard ML; Puri BK; Taylor-Robinson SD; Hajnal JV; Saeed N; Bydder GM. (Oct 2002). Changes in brain size with treatment in patients with hyper- or hypothyroidism. AJNR Am J Neuroradiol. 23:1539-1544.
  • Lim AK; Patel N; Gedroyc WM; Blomley MJ; Hamilton G; Taylor-Robinson SD. (Aug 2002). Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques. Br J Radiol. 75:695-699.
  • Dick EA; Taylor-Robinson SD; Thomas HC; Gedroyc WM. (May 2002). Ablative therapy for liver tumours. Gut. 50:733-739.
  • Lim AKP; Patel N; Hamilton G; Blomley MJK; Cosgrove DO; Foster GR; Goldin RD; Thomas HC; et alTaylor-Robinson SD. (1 Apr 2002). A prospective assessment of hepatic vein transit times using microbubble-enhanced ultrasound in non-invasive grading of hepatitis C (HCV) related liver disease. GUT. 50:A53-A53. Author weblink.
  • Khan SA; Carmichael PL; Taylor-Robinson SD; Habib N; Thomas HC. (1 Apr 2002). Evidence of an environmental cause for the rise in cholangiocarcinoma. GUT. 50:A54-A54. Author weblink.
  • Forton DM; Prince M; Allsop J; Patel N; Goldblatt J; Thomas HC; Bassendine M; Jones DEJ; et alTaylor-Robinson SD. (1 Apr 2002). Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis. GUT. 50:A46-A46. Author weblink.
  • Forton DM; Taylor-Robinson SD; Thomas HC. (Mar 2002). Reduced quality of life in hepatitis C--is it all in the head?. J Hepatol. 36:435-438.
  • Forton DM; Thomas HC; Murphy CA; Allsop JM; Foster GR; Main J; Wesnes KA; Taylor-Robinson SD. (Feb 2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 35:433-439. DOI.
  • Taylor-Robinson SD. (Feb 2002). Operation Lifeline Sudan. J Med Ethics. 28:49-51.
  • Ashrafian H; Taylor-Robinson SD; Calam J; Playford RJ. (19 Jan 2002). Once you start, you can't stop. Lancet. 359:226. DOI.
  • Changani KK; Jalan R; Cox IJ; Ala-Korpela M; Bhakoo K; Taylor-Robinson SD; Bell JD. (Oct 2001). Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut. 49:557-564.
  • Forton DM; Allsop JM; Main J; Foster GR; Thomas HC; Taylor-Robinson SD. (7 Jul 2001). Evidence for a cerebral effect of the hepatitis C virus. Lancet. 358:38-39. DOI.
  • Taylor-Robinson SD; Toledano MB; Arora S; Keegan TJ; Hargreaves S; Beck A; Khan SA; Elliott P; et alThomas HC. (Jun 2001). Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut. 48:816-820.
  • Goolamali SI; Taylor-Robinson SD. (May 2001). Endoscopic retrograde cholangiopancreatography appearances of early primary sclerosing cholangitis. J Clin Gastroenterol. 32:460-461.
  • Forton D; Murphy C; Allsop J; Main J; Foster GR; Thomas HC; Taylor-Robinson SD. (1 Apr 2001). Correlation between neuropsychometric scores and cerebral proton magnetic resonance spectroscopy (1H-MRS) in chronic hepatitis C infection. JOURNAL OF HEPATOLOGY. 34:160-160. Author weblink DOI.
  • Cagnin A; Taylor-Robinson SD; Forton DM; Banati RB. (1 Apr 2001). In vivo quantification of cerebral 'peripheral benzodiazepine binding site' in minimal hepatic encephalopathy: A [11C]R-PK11195 positron emission tomography study. JOURNAL OF HEPATOLOGY. 34:58-58. Author weblink DOI.
  • Patel N; Forton DM; Hamilton G; Coutts GA; Thomas HC; Taylor-Robinson SD. (1 Apr 2001). Intracellular pH of the brain in chronic hepatic encephalopathy: An in vivo phosphorus-31 MR spectroscopy study. JOURNAL OF HEPATOLOGY. 34:52-52. Author weblink DOI.
  • Patel N; Blomley MJ; Cosgrove DO; Harvey CJ; Thomas HC; Taylor-Robinson SD. (1 Apr 2001). Liver vascular transit times measured after ultrasound contrast injection: A measure of diffuse liver disease?. JOURNAL OF HEPATOLOGY. 34:225-225. Author weblink DOI.
  • Forton DM; Hargarden N; Thomas HC; Taylor-Robinson SD. (1 Mar 2001). Correlation between cerebral proton magnetic resonance spectroscopy (H-1 MRS) and neuropsychometric abnormalities in patients with chronic hepatitis C (HCV) infection. GUT. 48:A66-A67. Author weblink.
  • Patel N; Forton DM; Hamilton G; Coutts GA; Thomas HC; Taylor-Robinson SD. (1 Mar 2001). Intracellular pH of the brain in chronic hepatic encephalopathy (HE): A P-31 MR spectroscopy (MRS) study. GUT. 48:A22-A23. Author weblink.
  • Khan SA; Taylor-Robinson SD; Toledano MB; Elliott P; Thomas HC. (1 Mar 2001). Worldwide trends in mortality rates for hepatobiliary and pancreatic tumours, 1979-1997. GUT. 48:A103-A103. Author weblink.
  • Taylor-Robinson SD. (Jan 2001). Applications of magnetic resonance spectroscopy to chronic liver disease. Clin Med. 1:54-60.
  • Khan SA; Taylor-Robinson SD; Toledano MB; Beck A; Elliott P; Thomas HC. (1 Oct 2000). Comparison of trends in mortality rates rates for primary liver tumours worldwide 1979-1997. HEPATOLOGY. 32:228A-228A. Author weblink.
  • Forton DM; Taylor-Robinson SD; Karayiannis P; Thomas HC. (1 Oct 2000). Identification of brain-specific quasispecies variants of hepatitis C virus (HCV) consistent with viral replication in the central nervous system. HEPATOLOGY. 32:269A-269A. Author weblink.
  • Patel N; Forton DM; Coutts GA; Thomas HC; Taylor-Robinson SD. (Sep 2000). Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study. Metab Brain Dis. 15:223-240.
  • Bell JD; Taylor-Robinson SD. (Aug 2000). Assessing gene expression in vivo: magnetic resonance imaging and spectroscopy. Gene Ther. 7:1259-1264. DOI.
  • Changani KK; Fuller BJ; Bell JD; Taylor-Robinson S; Davidson BR. (Aug 2000). Bioenergetic targeting during organ preservation: (31)P magnetic resonance spectroscopy investigations into the use of fructose to sustain hepatic ATP turnover during cold hypoxia in porcine livers. Cryobiology. 41:72-87. DOI.
  • Jarman PR; Bhatia KP; Davie C; Heales SJ; Turjanski N; Taylor-Robinson SD; Marsden CD; Wood NW. (Jul 2000). Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large family. Mov Disord. 15:648-657.
  • Aspinall RJ; Taylor-Robinson SD. (Jul 2000). Transient "polyposis coli". J Clin Gastroenterol. 31:92-93.
  • Khan SA; Taylor-Robinson SD; Toledano MB; Arora S; Hargreaves S; Beck A; Elliott P; Thomas HC. (1 Apr 2000). Increase in mortality rates for intrahepatic cholangiocarcinoma in England & Wales 1968-1996. GUT. 46:A74-A74. Author weblink.
  • Jalan R; Turjanski N; Taylor-Robinson SD; Koepp MJ; Richardson MP; Wilson JA; Bell JD; Brooks DJ. (Apr 2000). Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut. 46:546-552.
  • Aspinall RJ; Taylor-Robinson SD. (Mar 2000). Images in hepatology. Radiological caput medusae. J Hepatol. 32:535.
  • Hu MT; Taylor-Robinson SD; Chaudhuri KR; Bell JD; Labbé C; Cunningham VJ; Koepp MJ; Hammers A; et alMorris RG; Turjanski N; Brooks DJ. (Feb 2000). Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain. 123 ( Pt 2):340-352.
  • Khan SA; Taylor-Robinson SD; Toledano M; Elliott P; Beck A; Thomas HC. (1 Jan 2000). Increase in mortality rates for intrahepatic cholangiocarcinoma in England & Wales 1968-1996. JOURNAL OF HEPATOLOGY. 32:117-117. Author weblink DOI.
  • Forton DM; Hargarden N; Thomas HC; Taylor-Robinson SD. (1 Jan 2000). Proton cerebral magnetic resonance spectroscopy and neuropsychometric abnormalities in patients with chronic hepatitis C infection. JOURNAL OF HEPATOLOGY. 32:30-30. DOI.
  • Mathur R; Cox IJ; Oatridge A; Shephard DT; Shaw RJ; Taylor-Robinson SD. (Dec 1999). Cerebral bioenergetics in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 160:1994-1999.
  • Marcus CD; Taylor-Robinson SD; Cox IJ; Sargentoni J; Shaunak S. (Dec 1999). Reversible alterations in brain metabolites during therapy for disseminated nocardiosis using proton magnetic resonance spectroscopy. Metab Brain Dis. 14:231-237.
  • Taylor-Robinson SD; Buckley C; Changani KK; Hodgson HJ; Bell JD. (Oct 1999). Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver. 19:389-398.
  • Taylor-Robinson SD; Thomas HC; Arora S; Hargreaves S. (4 Sep 1999). Increased mortality from liver cancer in England and Wales is not related to hepatitis C. BRITISH MEDICAL JOURNAL. 319:640-640. Author weblink.
  • Hodgson RS; Jackson JE; Taylor-Robinson SD; Walters JR. (Sep 1999). Superior mesenteric vein stenosis complicating Crohn's disease. Gut. 45:459-462.
  • Changani KK; Fuller BJ; Bell JD; Taylor-Robinson SD; Moore DP; Davidson BR. (15 Aug 1999). Improved preservation solutions for organ storage: a dynamic study of hepatic metabolism. Transplantation. 68:345-355.
  • de Jode MG; Lamb GM; Thomas HC; Taylor-Robinson SD; Gedroyc WM. (Aug 1999). MRI guidance of infra-red laser liver tumour ablations, utilising an open MRI configuration system: technique and early progress. J Hepatol. 31:347-353.
  • Hu MT; Taylor-Robinson SD; Chaudhuri KR; Bell JD; Morris RG; Clough C; Brooks DJ; Turjanski N. (Jul 1999). Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry. 67:20-26.
  • Burton MJ; Seery JP; Taylor-Robinson SD; Scott-Coombes DM; Jackson JE. (Jul 1999). Jejunal intussusception secondary to Peutz--Jeghers type hamartoma diagnosed on angiography. Clin Radiol. 54:476-478.
  • Changani KK; Ala-Korpela M; Fuller BJ; Mierisova S; Bryant DJ; Taylor-Robinson SD; Davidson BR; Bell JD. (Jun 1999). Incorporation of metabolite prior knowledge for data analysis: biochemical implications of dynamic 31P NMR ex vivo pig liver studies. NMR Biomed. 12:197-204.
  • Albrecht T; Blomley MJ; Cosgrove DO; Taylor-Robinson SD; Jayaram V; Eckersley R; Urbank A; Butler-Barnes J; et alPatel N. (8 May 1999). Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet. 353:1579-1583. DOI.
  • Taylor-Robinson SD. (May 1999). To South Sudan with operation lifeline Sudan and UNICEF. J R Coll Physicians Lond. 33:276-279.
  • Taylor-Robinson SD; Turjanski N; Bhattacharya S; Seery JP; Sargentoni J; Brooks DJ; Bryant DJ; Cox IJ. (Mar 1999). A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease. Metab Brain Dis. 14:45-55.
  • Albrecht T; Blomley MJK; Cosgrove DO; Taylor-Robinson SD; Jayaram V; Eckersley R; Urbank A; Butler-Barnes J; et alPatel N. (1 Jan 1999). Transit-time studies with Levovist in patients with and without hepatic cirrhosis: A promising new diagnostic tool. EUROPEAN RADIOLOGY. 9:S377-S381. Author weblink DOI.
  • Thomas HC; Torok ME; Forton DM; Taylor-Robinson SD. (1 Jan 1999). Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. JOURNAL OF HEPATOLOGY. 31:152-159. Author weblink DOI.
  • Blomley MJ; Albrecht T; Cosgrove DO; Jayaram V; Eckersley RJ; Patel N; Taylor-Robinson S; Bauer A; et alSchlief R. (Dec 1998). Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology. 209:862-866.
  • Changani KK; Fuller BJ; Bell JD; Taylor-Robinson SD; Davidson BR. (1 Oct 1998). Fructose enhanced preservation fluid reduces hepatic ATP hydrolysis during cold storage. HEPATOLOGY. 28:270A-270A. Author weblink.
  • Taylor-Robinson SD; Arora S; Hargreaves S; Thomas HC. (1 Oct 1998). Increase in cholangiocarcinoma in England and Wales 1979-1995. HEPATOLOGY. 28:242A-242A. Author weblink.
  • Wilson JA; Taylor-Robinson SD; Bryant DJ; Taylor KM; Harris DN. (Sep 1998). Localised cerebral phosphorus-31 MR spectroscopy in man before and immediately after coronary bypass surgery with hypothermic cardiopulmonary bypass. Metab Brain Dis. 13:191-200.
  • Harris DN; Wilson JA; Taylor-Robinson SD; Taylor KM. (Sep 1998). Magnetic resonance spectroscopy of high-energy phosphates and lactate immediately after coronary artery bypass surgery. Perfusion. 13:328-333.
  • Seery JP; Bryant DJ; Jenkinson G; Schwieso JE; Houlden HJ; Changani KK; Hodgson HJF; Taylor-Robinson SD. (1 Aug 1998). Intravenous intralipid infusion in hepatic steatosis: an in vivo hepatic phosphorus-31 magnetic resonance spectroscopy study. HEPATOLOGY RESEARCH. 12:50-58. Author weblink DOI.
  • Changani KK; Taylor-Robinson SD; Bell JD; Fuller BJ; Davidson BR. (15 Jun 1998). Noninvasive metabolic assessment of human donor livers: metabolite assignment in 31P magnetic resonance spectroscopy. Transplantation. 65:1526-1528.
  • Changani KK; Taylor-Robinson SD; Bell JD; Fuller BJ; Davidson BR. (15 Jun 1998). Noninvasive metabolic assessment of human donor livers: Metabolite assignment in P-31 magnetic resonance spectroscopy. TRANSPLANTATION. 65:1526-1527. Author weblink DOI.
  • Marcus CD; Taylor-Robinson SD; Sargentoni J; Ainsworth JG; Frize G; Easterbrook PJ; Shaunak S; Bryant DJ. (Jun 1998). 1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities. Metab Brain Dis. 13:123-136.
  • Changani KK; Davidson BR; Bell JD; Taylor-Robinson SD; Fuller BJ. (1 May 1998). A comparison of ATP recovery or phosphomonoester inorganic phosphate ratio to assess metabolic activity in liver at hypothermia: A P-31 NMR study. CRYO-LETTERS. 19:183-188. Author weblink.
  • Changani KK; Davidson BR; Bell JD; Taylor-Robinson SD; Fuller BJ. (1 May 1998). Enhanced energy metabolism at hypothermia following addition of a prostacyclin derivative in porcine liver. CRYO-LETTERS. 19:131-140. Author weblink.
  • Taylor-Robinson SD; Sargentoni J; Bell JD; Thomas EL; Marcus CD; Changani KK; Saeed N; Hodgson HJ; et alDavidson BR; Burroughs AK; Rolles K; Foster CS; Cox IJ. (May 1998). In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut. 42:735-743.
  • Polak J; Oakley CM; Yacoub M; Mikhail G; Taylor-Robinson SD. (May 1998). Primary pulmonary hypertension: pathologist as patient. J R Coll Physicians Lond. 32:225-230.
  • Hu MT; Taylor-Robinson SD; Bell JD; Clough C; Brooks DJ; Chaudhuri KR; Turjanski N. (1 Apr 1998). Evidence for subclinical cortical dysfunction in Parkinson's disease patients: A proton magnetic resonance spectroscopy (H-1 MRS) study. NEUROLOGY. 50:A388-A388. Author weblink.
  • Changani KK; Bell JD; Brooks KJ; Fuller BJ; Taylor-Robinson SD; Davidson BR; Brookes PS; Bates TE. (1 Mar 1998). Depression of liver mitochondrial complex II-linked respiration following cooling: Beneficial effects of using a prostacyclin analogue during hypothermia. CRYO-LETTERS. 19:71-78. Author weblink.
  • Seery JP; Aspinall RJ; Taylor-Robinson SD. (Mar 1998). Diagnosis and treatment of chronic hepatic encephalopathy. Hosp Med. 59:200-204.
  • Ala-Korpela M; Changani KK; Hiltunen Y; Bell JD; Fuller BJ; Bryant DJ; Taylor-Robinson SD; Davidson BR. (Nov 1997). Assessment of quantitative artificial neural network analysis in a metabolically dynamic ex vivo 31P NMR pig liver study. Magn Reson Med. 38:840-844.
  • Taylor-Robinson SD; Foster GR; Arora S; Hargreaves S; Thomas HC. (18 Oct 1997). Increase in primary liver cancer in the UK, 1979-94. Lancet. 350:1142-1143. DOI.
  • Barnard ML; Changani KK; Taylor-Robinson SD. (Oct 1997). The role of magnetic resonance spectroscopy in the assessment of kidney viability. Scand J Urol Nephrol. 31:487-492.
  • Davidson BR; Barnard ML; Changani KK; Taylor-Robinson SD. (Sep 1997). Liver transplantation: current and potential applications of magnetic resonance spectroscopy. Liver Transpl Surg. 3:481-493.
  • Taylor-Robinson SD; Sargentoni J; Bell JD; Saeed N; Changani KK; Davidson BR; Rolles K; Burroughs AK; et alHodgson HJ; Foster CS; Cox IJ. (Aug 1997). In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver. 17:198-209.
  • Taylor-Robinson SD; Jackson N; Buckley C. (Jun 1997). Helicobacter pylori, ammonia and the brain. Gut. 40:805-806.
  • Weir A; Taylor-Robinson SD; Poole S; Pignatelli M; Walters JF; Calam J. (Mar 1997). Cytoplasmic antineutrophil cytoplasmic antibody-positive vasculitis associated with ulcerative colitis. Am J Gastroenterol. 92:506-508.
  • Changani KK; Fuller BJ; Bryant DJ; Bell JD; Ala-Korpela M; Taylor-Robinson SD; Moore DP; Davidson BR. (Feb 1997). Non-invasive assessment of ATP regeneration potential of the preserved donor liver. A 31P MRS study in pig liver. J Hepatol. 26:336-342.
  • Thomas EL; Taylor-Robinson SD; Barnard ML; Frost G; Sargentoni J; Davidson BR; Cunnane SC; Bell JD. (Jan 1997). Changes in adipose tissue composition in malnourished patients before and after liver transplantation: a carbon-13 magnetic resonance spectroscopy and gas-liquid chromatography study. Hepatology. 25:178-183. DOI.
  • Seery JP; Taylor-Robinson SD. (Dec 1996). The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy. J Hepatol. 25:988-998.
  • Aspinall RJ; Seery JP; Taylor-Robinson SD; Habib N. (15 Nov 1996). Comments on "arterialization of the portal vein in orthotopic and auxiliary liver transplantation". Transplantation. 62:1375-1376.
  • Jalan R; Seery JP; Taylor-Robinson SD. (Oct 1996). Review article: pathogenesis and treatment of chronic hepatic encephalopathy. Aliment Pharmacol Ther. 10:681-697.
  • Changani KK; Fuller BJ; Bell JD; Bryant DJ; Moore DP; Taylor-Robinson SD; Davidson BR. (27 Sep 1996). Hepatic nucleotide triphosphate regeneration after hypothermic reperfusion in the pig model: an in vitro P-NMR study. Transplantation. 62:787-793.
  • Jalan R; Taylor-Robinson SD; Hodgson HJ. (Sep 1996). In vivo hepatic magnetic resonance spectroscopy: clinical or research tool?. J Hepatol. 25:414-424.
  • Taylor-Robinson SD; Sargentoni J; Oatridge A; Bryant DJ; Hajnal JV; Marcus CD; Seery JP; Hodgson HJ; et aldeSouza NM. (Sep 1996). MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis. 11:249-268.
  • Lambiase P; Seery JP; Taylor-Robinson SD; Thompson JN; Hughes JM; Walters JR. (Sep 1996). Resolution of panniculitis after placement of pancreatic duct stent in chronic pancreatitis. Am J Gastroenterol. 91:1835-1837.
  • Jalan R; Sargentoni J; Coutts GA; Bell JD; Rolles K; Burroughs AK; Taylor Robinson SD. (Jul 1996). Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. Gut. 39:141-146.
  • Taylor-Robinson SD; Weeks RA; Bryant DJ; Sargentoni J; Marcus CD; Harding AE; Brooks DJ. (Mar 1996). Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory. Mov Disord. 11:167-173. DOI.
  • Thomas EL; Frost G; Barnard ML; Bryant DJ; Taylor-Robinson SD; Simbrunner J; Coutts GA; Burl M; et alBloom SR; Sales KD; Bell JD. (Feb 1996). An in vivo 13C magnetic resonance spectroscopic study of the relationship between diet and adipose tissue composition. Lipids. 31:145-151.
  • Taylor-Robinson SD; Thomas EL; Sargentoni J; Marcus CD; Davidson BR; Bell JD. (17 Oct 1995). Cirrhosis of the human liver: an in vitro 31P nuclear magnetic resonance study. Biochim Biophys Acta. 1272:113-118.
  • Taylor-Robinson SD; Oatridge A; Hajnal JV; Burroughs AK; McIntyre N; deSouza NM. (Jun 1995). MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis. 10:175-188.
  • Menon DK; Harris M; Sargentoni J; Taylor-Robinson SD; Cox IJ; Morgan MY. (Mar 1995). In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology. 108:776-788.
  • Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; et alBurroughs AK; Morgan MY. (Feb 1995). Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology. 21:417-427.
  • Taylor-Robinson SD; Sargentoni J; Marcus CD; Morgan MY; Bryant DJ. (Dec 1994). Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis. 9:347-359.
  • Taylor-Robinson SD; Sargentoni J; Mallalieu RJ; Bell JD; Bryant DJ; Coutts GA; Morgan MY. (Nov 1994). Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology. 20:1173-1178.
  • Taylor-Robinson SD; Weeks RA; Sargentoni J; Marcus CD; Bryant DJ; Harding AE; Brooks DJ. (7 May 1994). Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy. Lancet. 343:1170.

Books

  • Williams R; Taylor-Robinson SD. Clinical Dilemmas in Primary Liver Cancer. . Wiley (17 Jan 2012).
  • So PW; Bhakoo KK; Cox IJ; Taylor-Robinson SD; Bell JD. Conn PM (ed). Essential Bioimaging Methods (Chapter 18: The application of magnetic resonance imaging and spectroscopy to gene therapy). 373-397. Academic Press, Burlington (1 Nov 2009).
  • Aspinall RJ; Taylor-Robinson SD. Mosby's Colour Atlas and Text of Gastroenterology and Liver Disease. (2002).

Chapters in books

  • shariff MI; Taylor-Robinson SD. Dipstick markers for diagnosis: Feasible or not?. In Clinical Dilemmas in Primary Liver Cancer. . Williams R (ed); Taylor-Robinson SD (ed). Wiley (17 Jan 2012).
  • Khan SA; Toledano MB; Ahmed M; Zabron AA; Taylor-Robinson SD. Liver Cancer: The view from the United Kingdom. In Clinical Dilemmas in Primary Liver Cancer. Williams R (ed); Taylor-Robinson SD (ed). Wiley (17 Jan 2012).
  • Sharif AW; Khan SA; Lindley CM; Lampejo TL; Goldin RJ; Cox IJ; Taylor-Robinson SD. Cholangiocarcinoma. In Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases. 596-607. Mahtab (ed). Elsevier India (1 Jan 2009).
  • Gess M; Forton DM; Thomas HC. Affective and cognitive disorders in hepatitis C infection: are they real and what are the mechanisms?. In Clinical Dilemmas in Viral Liver Disease. 19-23. Foster G (ed); Reddy KR (ed). Wiley-Blackwell, Chichester (2010).
  • So PW; Bhakoo KK; Cox IJ; Taylor-Robinson SD; Bell JD. The application of magnetic resonance imaging and spectroscopy to gene therapy. In Essential Bioimaging Methods. 373-397. Conn PM (ed). Academic Press, Burlington (26 Oct 2009).
  • Forton DM; Allsop J; Thomas HC; Taylor-Robinson SD. Central nervous system involvement in hepatitis C virus infection: What to measure?. In Hepatic Encephalopathy and Nitrogen Metabolism. 284-290. Häussinger D (ed); Kirchels G (ed); Schless F (ed). Springer Science, Dordrecht (11 Jul 2006).
  • Taylor-Robinson SD; Cobbold JFL; Crossey MME; Cox IJ. To perform a liver biopsy or not? Possible non-invasive alternatives. In Horizons in Medicine. 21:103-112. Royal College of Physicians of London, London (2009).
  • Lim AK; Khan SA; Cox IJ; Taylor-Robinson SD. Nuclear magnetic resonance spectroscopy of in the study of human liver. In Nuclear magnetic resonance spectroscopy in the study of neoplastic tissue. 295-311. Tosi R (ed); Tugnoli V (ed). Nova Science, Hauppauge, New York (1 Jan 2005).
  • Forton DM; Taylor-Robinson SD; Cox IJ; Thomas HC. Central nervous system complications. In Viral hepatitis. 3:482-495. Thomas HC (ed); Lemon SM (ed); Zuckerman AJ (ed). Blackwell, Oxford (2005).
  • Forton DM; Prince M; Allsop J; Patel N; Goldblatt J; Thomas HC; Bassendine M; Jones DEJ; et alTaylor-Robinson SD. Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic primary biliary cirrhosis. In Encephalopathy and nitrogen metabolism in liver failure. 173-176. Jones EA (ed); Meijer AJ (ed); Chamuleau RAFM (ed). Kluwer, Dordrecht (31 May 2003).
  • Forton DM; Fletcher A; Thomas HC; Taylor-Robinson SD. Does Hepatitis C Virus Affect the Brain? A proton magnetic resonance study (1H MRS). In Advances in hepatic encephalopathy & metabolism in liver disease. 325-329. Bozkaya H (ed); Foundation TG (ed). Ankara University Press, Ankara (2000).
  • Taylor-Robinson SD; Marcus CM. Tissue behaviour measurements using phosphorus-31 NMR. Tissue behaviour measurements using phosphorus-31 NMR. In Methods in biomedical magnetic resonance imaging and spectroscopy. 1223-1229. Young IR (ed). John Wiley, Chichester (27 Sep 2000).
  • Taylor-Robinson SD; Marcus CM. Tissue behaviour measurements using phosphorus-31 NMR. In Encyclopedia of Nuclear Magnetic Resonance: Advances in NMR. 8:4765-4771. Grant DM (ed); Harris RK (ed). John Wiley, Chichester (1996).
  • Taylor-Robinson SD; Barnard ML; Marcus CM. MRS in transplantation. In MR spectroscopy. 175-210. Young IR (ed); Charles HC (ed). Martin Dunitz, London (1996).
  • Taylor-Robinson SD; Bell JD; Sargentoni J; Bryant DJ; Mallalieu RJ; Morgan MY. Cerebral 31P MRS in patients with chronic hepatic encephalopathy. In Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange. 372-377. Capocaccia L (ed); Merli M (ed); Riggio O (ed). CRC Press, Boca Raton (27 Dec 1994).
  • Sharif AW; Khan SA; Lindley CM; Lampejo TM; Goldin RD; Cox IJ; Taylor-Robinson SD. Cholangiocarcinoma. In Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases. 596-607. Al-Mahtab M (ed); Rahman S (ed). Elsevier, Noida (2009).
  • Dick EA; Taylor-Robinson SD; Gedroyc WM. Laser and focused ultrasound ablation of primary and secondary liver tumours. In Multi-treatment modalities of liver tumours. 197-210. Kluwer Academic/Plenum Publishers, New York (2002).

Conferences

  • Wadsworth CA; Dixon PH; Zabron AA; Wong JH; Chapman MH; McKay SC; Sharif AW; Spalding DR; et alPereira SP; Wasan HS; Thomas HC; Taylor-Robinson SD; Whittaker JC; Williamson C; Khan SA. GENETIC VARIATION IN BILIARY TRANSPORTERS AS A SUSCEPTIBILITY FACTOR FOR CHOLANGIOCARCINOMA. 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), 2011. 54:S109-S109. ELSEVIER SCIENCE BV (1 Mar 2011). Author weblink.
  • Wadsworth CA; Dixon PH; Zabron AA; Wong JH; Chapman MH; McKay SC; Spalding DR; Pereira SP; et alWasan HS; Thomas HC; Taylor-Robinson SD; Whittaker JC; Williamson C; Khan SA. COMMON GENETIC VARIATION IN NATURAL KILLER CELL RECEPTOR PROTEIN G2D DOES NOT MODIFY SUSCEPTIBILITY TO SPORADIC CHOLANGIOCARCINOMA. 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), 2011. 54:S108-S109. ELSEVIER SCIENCE BV (1 Mar 2011). Author weblink.
  • McPhail MJ; Leech R; Grover VP; Fitzpatrick J; Dhanjal NS; Saxby BK; Wesnes K; Thomas HC; et alWise RJ; Taylor-Robinson SD. FUNCTIONAL CORE MODULATION FOLLOWING TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY WITH L-ORNITHINE L-ASPARTATE: A POTENTIAL NOVEL MECHANISM OF ACTION. 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), 2011. 54:S74-S75. ELSEVIER SCIENCE BV (1 Mar 2011). Author weblink.
  • Bridge SH; Sheridan DA; Felmlee D; Thomas H; Crossey M; Taylor-Robinson SD; Toms GL; Neely D; et alBassendine MF. APOLIPOPROTEIN E AND LOW-DENSITY, APOLIPOPROTEIN B ASSOCIATED LIPOVIRAL PARTICLES IN CHRONIC HEPATITIS C INFECTION: EVIDENCE FOR GENOTYPE-SPECIFIC MODULATION OF LIPID PATHWAYS. 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), 4 Nov 2011 - 8 Nov 2011. 54:1316A-1316A. WILEY-BLACKWELL (1 Oct 2011). Author weblink.
  • Dhar A; Anstee QM; Cobbold JF; Stove JA; Martinelli AL; Taylor-Robinson SD; Thursz MR. ANTICOAGULATION FOR LIVER FIBROSIS: A PILOT STUDY IN HEPATITIS C INFECTED PATIENTS. 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 29 Oct 2010 - 2 Nov 2010. 52:1133A-1133A. WILEY-BLACKWELL (1 Oct 2010). Author weblink.
  • Bridge SH; Sheridan DA; Felmlee D; Thomas H; Taylor-Robinson SD; Neely D; Toms GL; Bassendine MF. MEASUREMENT OF LOW-DENSITY APOLIPOPROTEIN B ASSOCIATED LIPOVIRAL PARTICLES IN HEPATITIS C VIRUS GENOTYPE 1 INFECTION IS MORE CLINICALLY RELEVANT THAN TOTAL VIRAL LOAD. 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 29 Oct 2010 - 2 Nov 2010. 52:435A-435A. WILEY-BLACKWELL (1 Oct 2010). Author weblink.
  • Wadsworth CA; Dixon PH; Zabron AA; Wong JH; Chapman MH; McKay SC; Spalding DR; Pereira SP; et alWasan HS; Thomas HC; Taylor-Robinson SD; Whittaker JC; Williamson C; Khan SA. GENETIC VARIATION IN NATURAL KILLER CELL RECEPTOR PROTEIN G2D DOES NOT MODIFY SUSCEPTIBILITY TO SPORADIC CHOLANGIOCARCINOMA. Annual Meeting on British-Society-of-Gasenterology, 14 Mar 2011 - 17 Mar 2011. 60. B M J PUBLISHING GROUP (1 Apr 2011). DOI.
  • Garvey L; Higgs C; Mohammed P; Hill A; Allsop JM; Taylor-Robinson SD; Nelson M; Winston A. Changes in cerebral function parameters in HIV-1 infected subjects undergoing a treatment simplification to darunavir/ritonavir: a randomized, prospective study. 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, 4 Nov 2010 - 6 Nov 2010. 15:A70-A70. INT MEDICAL PRESS LTD (1 Jan 2010). Author weblink.
  • Garvey L; Higgs C; Mohammed P; Hill A; Allsop JM; Taylor-Robinson SD; Nelson M; Winston A. Changes in cerebral function parameters in HIV-1 infected subjects undergoing a treatment simplification to darunavir/ritonavir: a randomized, prospective study. 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, 4 Nov 2010 - 6 Nov 2010. 15:A70-A70. INT MEDICAL PRESS LTD (1 Jan 2010). Author weblink.
  • Zabron AA; Horneffer-Van der Sluis VM; Geirula M; Wadsworth CA; Laird F; Thillainayagam AV; Vlavianos P; Westaby D; et alTaylor-Robinson SD; Edwards RJ; Khan SA. PROTEOMIC ANALYSIS OF BILE IN BENIGN AND MALIGNANT PANCREATOBILIARY DISEASE. Annual General Meeting of the British-Society-of-Gastroenterology, 22 Mar 2010 - 25 Mar 2010. 59:A82-A83. B M J PUBLISHING GROUP (1 Apr 2010). DOI.
  • Williams HRT; Cox IJ; Walker DG; Sato H; Taylor-Robinson SD; Marshall SE; Orchard TR. CORRELATING URINARY METABOLIC PROFILES WITH SEROLOGICAL AND GENETIC DETERMINANTS OF INFLAMMATORY BOWEL DISEASE. Annual General Meeting of the British-Society-of-Gastroenterology, 22 Mar 2010 - 25 Mar 2010. 59:A67-A68. B M J PUBLISHING GROUP (1 Apr 2010). DOI.
  • Khan SA; Emadossadaty S; Taylor-Robinson SD; Elliott P; Thomas HC; Toledano MB. MISCLASSIFICATION OF HILAR (KLATSKIN) CHOLANGIOCARCINOMAS: AN INVESTIGATION OF CODING PRACTICE IN THE UK. 45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 14 Apr 2010 - 18 Apr 2010. 52:S221-S221. ELSEVIER SCIENCE BV (1 Jan 2010). Author weblink.
  • Tooley V; Fitzpatrick JA; McPhail MJW; Campbell L; Cobbold JF; Thomas HC; Taylor-Robinson SD. CHEST CIRCUMFERENCE IS MORE IMPORTANT THAN BODY MASS INDEX IN DETERMINING AGREEMENT BETWEEN OPERATORS PERFORMING FIBROSCAN (R). 45th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 14 Apr 2010 - 18 Apr 2010. 52:S167-S167. ELSEVIER SCIENCE BV (1 Jan 2010). Author weblink.
  • Wadsworth CA; Young IR; Rea M; Ahmad MM; Khorsandi SE; Davidson B; Khan S; Taylor-Robinson SD; et alSyms RR. A CATHETER-MOUNTED MAGNETIC RESONANCE DETECTOR COIL FOR BILIARY IMAGING: FIRST EX VIVO HUMAN HEPATOBILIARY IMAGES. 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 30 Oct 2009 - 3 Nov 2009. 50:740A-741A. JOHN WILEY & SONS INC (1 Oct 2009). Author weblink.
  • McPhail M; Grover VP; Julie F; Saxby B; Thomas H; Taylor-Robinson SD. LONGITUDINAL ASSESSMENT OF BRAIN VOLUMES DURING TREATMENT OF CHRONIC HEPATIC ENCEPHALOPATHY WITH L-ORTHININE-L-ASPARTATE. 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 30 Oct 2009 - 3 Nov 2009. 50:434A-434A. JOHN WILEY & SONS INC (1 Oct 2009). Author weblink.
  • Ahmad MM; Syms RRA; Young IR; Mathew B; Casperz W; Taylor-Robinson SD; Wadsworth CA; Gedroyc WMW. Catheter-based flexible microcoil RF detectors for internal magnetic resonance imaging. 19th MicroMechanics Europe Workshop, 28 Sep 2008 - 30 Sep 2008. 19. IOP PUBLISHING LTD (1 Jul 2009). Author weblink DOI.
  • Southern L; Grover VP; Worthington J; Thyssen M; Wylezinska-Arridge M; Patel N; Larkman DJ; Chapman R; et alTaylor-Robinson SD. RELATIONSHIP BETWEEN MRI PARAMETERS, MANGANESE LEVELS AND PBC-40 QUESTIONNAIRE DATA IN PRE-CIRRHOTIC PBC PATIENTS. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 22 Apr 2009 - 26 Apr 2009. 50:S251-S251. ELSEVIER SCIENCE BV (1 Jan 2009). Author weblink.
  • Adenugba A; Khan SA; Taylor-Robinson SD; Cox IJ; Toledano MB; Thillainayagam AV; Bansi DS; Gibson RW; et alThomas HC; Beck AC. POLYCHLORINATED BIPHENYLS IN BILE OF PATIENTS WITH BILIARY TRACT CANCER. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 22 Apr 2009 - 26 Apr 2009. 50:S188-S188. ELSEVIER SCIENCE BV (1 Jan 2009). Author weblink.
  • Cobbold JFL; Patel JH; Goldin RD; Crossey ME; Fitzpatrick I; Taylor-Robinson SD; Cox IJ. NON-INVASIVE ASSESSMENT OF HEPATIC LIPID COMPOSITION: LIPID POLYUNSATURATION DECREASES WITH INCREASING FIBROSIS IN CHRONIC HEPATITIS C. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 22 Apr 2009 - 26 Apr 2009. 50:S149-S150. ELSEVIER SCIENCE BV (1 Jan 2009). Author weblink.
  • Wadsworth CA; Syms RRA; Khan SA; Dickinson RJ; Gedroyc WMW; Thursz MR; Ahmad MM; Awan SA; et alCaspersz W; Taylor-Robinson SD; Young IR. A CATHETER-MOUNTED MAGNETIC RESONANCE DETECTOR COIL FOR BILIARY IMAGING: FIRST IN VITRO BILIARY IMAGES. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A147-A147. B M J PUBLISHING GROUP (1 Apr 2009). Author weblink.
  • Toledano MB; Mehtan A; Elliott P; Taylor-Robinson SD; Thomas HC; Khan SA. UPDATE OF INCIDENCE AND MORTALITY RATES AND REVIEW OF DIAGNOSTIC TRENDS FOR INTRAHEPATIC CHOLANGIOCARCINOMA AND SELECTED HEPATOBILIARY TUMOURS IN ENGLAND AND WALES. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A67-A67. B M J PUBLISHING GROUP (1 Apr 2009). Author weblink.
  • Adenugba A; Khan SA; Taylor-Robinson SD; Cox I; Toledano MB; Thillainayagam AV; Bansi DS; Gibson RW; et alThomas HC; Beck AJ. POLYCHLORINATED BIPHENYLS IN BILE OF PATIENTS WITH BILIARY TRACT CANCER. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A67-A67. B M J PUBLISHING GROUP (1 Apr 2009). Author weblink.
  • Nassim P; Edwards RJ; Wasan H; Cox I; Toledano MB; Taylor-Robinson SD; Khan SA. PLASMA PROTEOMIC PROFILING OF PATIENTS WITH CHOLANGIOCARCINOMA. Annual Meeting of the British-Society-of-Gastroenterology, 23 Mar 2009 - 26 Mar 2009. 58:A17-A17. B M J PUBLISHING GROUP (1 Apr 2009).
  • Parviz N; Edwards RJ; Wasan HS; Taylor-Robinson SD; Toledano MB; Cox J; Khan S. PLASMA PROTEOMIC PROFILING OF PATIENTS WITH CHOLANGIOCARCINOMA. 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 31 Oct 2008 - 4 Nov 2008. 48:984A-985A. JOHN WILEY & SONS INC (1 Oct 2008). Author weblink.
  • Lim AKP; Harvey CJ; Taylor-Robinson SD; Blomley MJK; Cosgrove DO. Use of ultrasound contrast agents in hepatology. Falk Symposium on Medical Imaging in Gastroenterology and Hepatology, 28 Sep 2001 - 29 Sep 2001. 124:132-139. SPRINGER (1 Jan 2002). Author weblink.
  • Grover VP; Pavese N; Koh SB; Wylezinska M; McGuinness A; Saxby BK; Gerhard A; Forton DM; et alThomas HC; Brooks DJ; Taylor-Robinson SD. Evidence of neuroinflammation in patients with chronic hepatitis C: A cerebral positron emission tomography (PET) study. 43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver. 48:S275-S275. (Feb 2008).
  • Cobbold JF; Patel N; Goldin RD; Crossey ME; Morin SH; Fitzpatrick JA; Arridge M; Cox IJ; et alThomas HC; Cosgrove DO; Thursz MR; Leen EL; Taylor-Robinson SD. Early haemodynamic responses to interferon therapy in patients with chronic liver disease using contrast-enhanced ultrasound: Regulation by hepatic stellate cells?. 43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver. 48:S271-S271. (Feb 2008).
  • Williams HRT; Cox I; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; Thomas HJW; et alTeare JP; Jakobovits S; Zeki S; Welsh KI; Taylor-Robinson SD; Orchard TR. A urinary metabolic profile associated with Crohn's disease. Conference of the Scottish-Society-of-Gastroenterology-Audit on the Use of Adalimumab in the Management of Crohn's Disease. 57:A153-A153. (Jan 2008).
  • Cobbold JF; Chinthapalli S; Anstee Q; Goldin RD; Cox R; Thursz MR; Thomas HC; Taylor-Robinson SD; et alCox IJ. Dietary constituents in mice are reflected in the hepatic lipid profile as detected by carbon-13 magic angle spinning magnetic resonance spectroscopy. 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. 46:764A-765A. (Oct 2007).
  • Mehta SR; Barton N; Godsland IF; Robinson S; Bell JD; Thomas EL; Patel N; Fitzpatrick J; et alDurighel G; Pavitt D; Taylor-Robinson SD; Johnston DG. Impaired insulin-mediated non-esterified fatty acid suppression in patients with hepatic steatosis quantified using proton magnetic resonance spectroscopy. 43rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes. 50:S295-S296. (Sep 2007).
  • Cobbold JF; Anstee QM; Goldin RD; Cox RD; Thursz MR; Thomas HC; Taylor-Robinson SD; Cox IJ. Can disease progression in non-alcoholic fatty liver disease be predicted by metabolic biomarkers of lipid accumulation and peroxidation?. 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 11 Apr 2007 - 15 Apr 2007. 46:S265-S265. ELSEVIER SCIENCE BV (1 Jan 2007). Author weblink DOI.
  • Grover VP; Counsell SJ; Forton DM; Bradford EJ; Saxby BK; Thomas HC; Hajnal JV; Taylor-Robinson SD. Diffusion tensor and magnetisation transfer imaging of the brain at 3T in patients with cirrhosis and hepatic encephalopathy. 41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 26 Apr 2006 - 30 Apr 2006. 44:S75-S76. ELSEVIER SCIENCE BV (1 Jan 2006). Author weblink DOI.
  • Forton DM; Allsop J; Thomas HC; Taylor-Robinson SD. Central nervous system involvement in hepatitis C virus infection: what to measure?. 12th International Symposium on Hepatic Encephalopathy and Nitrogen Metabolism. 284-290. (2006).
  • Lim AKP; Patel N; Hamilton G; Hajnal JV; Taylor-Robinson SD. Assessing response of interferon treatment in hepatitis C virus (HCV) related liver disease using P-31 magnetic resonance spectroscopy. 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 13 Apr 2005 - 17 Apr 2005. 42:210-211. ELSEVIER SCIENCE BV (1 Apr 2005). Author weblink.
  • Khan SA; Mandeville K; Toledano MB; Thomas HC; Taylor-Robinson SD. Update of mortality and incidence rates for intrahepatic cholangiocarcinoma and other hepatobiliary tumours in England and Wales. 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, 13 Apr 2005 - 17 Apr 2005. 42:95-95. ELSEVIER SCIENCE BV (1 Apr 2005). Author weblink.
  • Mullenbach R; Tetlow N; Patel N; Hamilton G; Taylor-Robinson SD; Williamson C. ATP8B1 variations in a cohort of women with intrahepatic cholestasis of pregnancy (ICP). Annual Meeting of the British-Society-of-Gastroenterology, 21 Mar 2004 - 24 Mar 2004. 53:A16-A16. B M J PUBLISHING GROUP (1 Apr 2004). Author weblink.
  • Lim AKP; Patel N; Eckersley RJ; Bryant TH; Cosgrove DO; Thomas HC; Blomley MJ; Taylor-Robinson SD. Does microbubble ultrasound help with hepatocellular carcinoma screening in patients with HCV related liver disease?. Annual Meeting of the British-Society-of-Gastroenterology. 53:A79-A79. (Apr 2004).
  • Forton DM; Karayiannis P; Mahmud N; Taylor-Robinson SD; Thomas HC. Identification of brain specific hepatitis C (HCV) variants and comparative analysis of translation efficiencies of internal ribosomal entry site (IRES) RNA sequences. Annual Meeting of the British-Association-for-the-Study-of-the-Liver. 52:U17-U18. (May 2003).
  • Khan SA; Cox IJ; Bansi D; Thillainayagam A; Thomas HC; Taylor-Robinson SD. Analysis of bile in patients with and without pancreaticobiliary malignancy by in vitro 31-phosphorus NMR spectroscopy. Annual meeting of the British-Society-of-Gastroenterology. 52:A92-A92. (Apr 2003).
  • Lim AKP; Patel N; Hamilton G; Hajnal JV; Goldin R; Taylor-Robinson SD. Characterisation of diffuse liver disease in patients with hepatitis C using P-31 magnetic resonance spectroscopy (MRS). Annual meeting of the British-Society-of-Gastroenterology, 23 Mar 2003 - 26 Mar 2003. 52:A3-A3. BRITISH MED JOURNAL PUBL GROUP (1 Apr 2003). Author weblink.
  • Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine N; Thomas HC. Novel p53 mutations but lack of a mutational fingerprint in human intrahepatic cholangiocarcinoma. Annual meeting of the British-Society-of-Gastroenterology, 23 Mar 2003 - 26 Mar 2003. 52:A32-A32. BRITISH MED JOURNAL PUBL GROUP (1 Apr 2003). Author weblink.
  • Forton DM; Prince M; Allsop J; Patel N; Goldblatt J; Thomas HC; Bassendine M; Jones DEJ; et alTaylor-Robinson SD. Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis. 11th International Symposium on Hepatic Encephalopathy and Nitrogen Metabolism. 173-174. (2003).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook